![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
MR Tota and MI Schimerlik
Department of Biochemistry and Biophysics, Oregon State University, Corvallis 97331-6503.
The mechanism of action of the partial muscarinic agonist pilocarpine was analyzed in a reconstituted system consisting of the purified porcine atrial muscarinic receptor and the purified porcine atrial inhibitory guanine nucleotide-binding protein, Gi. When GTPase activity was measured as a function of receptor.agonist complex concentration at saturating concentrations of either the full agonist carbachol or pilocarpine, both ligands gave similar values of kcat (4.3 +/- 0.2 min- 1 for carbachol and 5.4 +/- 0.7 min-1 for pilocarpine); however, the observed dissociation constant for the ligand.receptor complex binding to Gi was about 4-fold lower for carbachol (0.81 +/- 0.19 nM) than for pilocarpine (3.02 +/- 0.83 nM). These results suggested that, in this system, the reduced activity of the partial agonist compared with the full agonist was the result of a decrease in affinity of the receptor.ligand complex for Gi, as opposed to differences in their relative abilities to activate the guanine nucleotide-binding protein. Several analogues of oxotremorine were also tested to determine their effects on the GTPase activity of Gi. Results from these studies indicate that the reconstituted system may be useful in determining structure-function relationships for muscarinic agonists with regard to receptor.Gi interactions.
This article has been cited by other articles:
|
|
 |
|
  D. J. Roberts, H. Lin, and P. G. Strange Mechanisms of Agonist Action at D2 Dopamine Receptors Mol. Pharmacol., December 1, 2004; 66(6): 1573 - 1579. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Zhang, M. Okamura, Z.-D. Guo, S. Niwa, and T. Haga Effects of Partial Agonists and Mg2+ Ions on the Interaction of M2 Muscarinic Acetylcholine Receptor and G Protein G{alpha}i1 Subunit in the M2-G{alpha}i1 Fusion Protein J. Biochem., May 1, 2004; 135(5): 589 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Simons, S. M. Biggs, A. Waller, T. Foutz, D. F. Cimino, Q. Guo, R. R. Neubig, W.-J. Tang, E. R. Prossnitz, and L. A. Sklar Real-time Analysis of Ternary Complex on Particles: DIRECT EVIDENCE FOR PARTIAL AGONISM AT THE AGONIST-RECEPTOR-G PROTEIN COMPLEX ASSEMBLY STEP OF SIGNAL TRANSDUCTION J. Biol. Chem., April 2, 2004; 279(14): 13514 - 13521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lazareno, V. Dolezal, A. Popham, and N. J. M. Birdsall Thiochrome Enhances Acetylcholine Affinity at Muscarinic M4 Receptors: Receptor Subtype Selectivity via Cooperativity Rather than Affinity Mol. Pharmacol., January 1, 2004; 65(1): 257 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. D. Alves, Z. Salamon, E. Varga, H. I. Yamamura, G. Tollin, and V. J. Hruby Direct Observation of G-protein Binding to the Human {delta}-Opioid Receptor Using Plasmon-Waveguide Resonance Spectroscopy J. Biol. Chem., December 5, 2003; 278(49): 48890 - 48897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Traynor, M. J. Clark, and A. E. Remmers Relationship between Rate and Extent of G Protein Activation: Comparison between Full and Partial Opioid Agonists J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 157 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gama and G. E. Breitwieser A Carboxyl-terminal Domain Controls the Cooperativity for Extracellular Ca2+ Activation of the Human Calcium Sensing Receptor. A STUDY WITH RECEPTOR-GREEN FLUORESCENT PROTEIN FUSIONS J. Biol. Chem., November 6, 1998; 273(45): 29712 - 29718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bot, A. D. Blake, S. Li, and T. Reisine Fentanyl and its Analogs Desensitize the Cloned Mu Opioid Receptor J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1207 - 1218. [Abstract] [Full Text]
|
|
|
|
|
|
W. K. Vogel, D. M. Sheehan, and M. I. Schimerlik Site-Directed Mutagenesis on the m2 Muscarinic Acetylcholine Receptor: The Significance of Tyr403 in the Binding of Agonists and Functional Coupling Mol. Pharmacol., December 1, 1997; 52(6): 1087 - 1094. [Abstract] [Full Text]
|
|
|
|
|
|
N. Yabaluri and F. Medzihradsky Down-regulation of µ-Opioid Receptor by Full but Not Partial Agonists Is Independent of G Protein Coupling Mol. Pharmacol., November 1, 1997; 52(5): 896 - 902. [Abstract] [Full Text]
|
|
|
|
|
|
W. K. Vogel, V. A. Mosser, D. A. Bulseco, and M. I. Schimerlik Porcine m2 Muscarinic Acetylcholine Receptor-Effector Coupling in Chinese Hamster Ovary Cells J. Biol. Chem., June 30, 1995; 270(26): 15485 - 15493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ghanouni, Z. Gryczynski, J. J. Steenhuis, T. W. Lee, D. L. Farrens, J. R. Lakowicz, and B. K. Kobilka Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the beta 2 Adrenergic Receptor J. Biol. Chem., June 29, 2001; 276(27): 24433 - 24436. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
